1. Pascual J, Teruel JL, Moya JL, Liano F, Jiminez-Mena M, Ortuno J. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study. Clin Nephrol. 1991;35:280–7.
2. Delano EG. Improvements in quality of life following treatment with r-HurEPO in anemic hemodialysis patients. Am J Kidney Dis. 1989;14:S14–18.
3. Wolcott DL, Marsh JT, La Rue A, Carr C, Nissenson AR. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis. 1989;14:478–85.
4. Schaefer RM, Kobot F, Heidland A. Impact of recombinant erythropoietin in sexual potency in hemodialysis patients: Contrib Nephrol. 1989;76:273–82.
5. NKF/DOQI Guidelines. Am J Kidney Dis. 2001;37:S186–7.